New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market
BCI Market Insights: PatentVest's report highlights the significant potential of brain-computer interfaces (BCIs) in addressing neurological disorders, projecting the U.S. market to exceed $400 billion, with early IP consolidation being crucial for long-term success.
Competitive Landscape: The report identifies key players in the BCI sector, such as Synchron and Neuralink, emphasizing the importance of intellectual property and strategic partnerships, while noting that universities still hold foundational patents essential for innovation.
Trade with 70% Backtested Accuracy
Analyst Views on MDBH
About MDBH
About the author
MDB Capital Appoints New Board Member
- Board Changes: MDB Capital Holdings announced the appointment of Jeb Terry to its Board of Directors while expressing gratitude to Susanne Meline for her contributions, effective February 1, 2026, reflecting the company's ongoing commitment to leadership optimization.
- New Board Member Background: Jeb Terry brings over 20 years of investment experience in microcap medical and biotechnology sectors, having founded Aberdeen Investment Management with a focus on undervalued opportunities in life sciences, which is expected to provide MDB with valuable industry insights.
- Strategic Implications: The addition of the new board member is seen as a crucial step for MDB in expanding its founder and investor community, with CEO Christopher Marlett emphasizing that Terry's expertise will aid the company's further development in public venture capital.
- Future Outlook: MDB Capital remains committed to driving the growth of innovative companies through its unique public venture capital platform, focusing on early public offerings and follow-on financings to support promising enterprises.
Keiretsu Forum Hosts Successful Investor Conferences, Attracting Over 150 Investors
- Investor Gathering: The Southeast Investor Conference and Mid-Atlantic Investor Summit attracted over 150 accredited investors and family offices, fostering in-depth discussions on early-stage capital and developing pathways for higher-quality deal flow.
- Significant Outcomes: The Atlanta conference featured 75 investors and over 20 presentations, showcasing 10 actively funding companies, which significantly boosted investor confidence and engagement in the market.
- Exit Strategy Optimization: The Philadelphia summit emphasized disciplined portfolio strategies and time-to-exit, proposing structured financing and 'restart' strategies to shorten exit timelines, thereby enhancing investor return expectations.
- Future Outlook: Keiretsu Forum plans to continue its Investor Summit series in 2026, expecting to attract more local innovation-stage startups and further drive the development of the regional investment ecosystem.
Keiretsu Forum Hosts Successful Investor Conferences, Attracting Over 150 Investors
- Investor Gathering: The Southeast Investor Conference and Mid-Atlantic Investor Summit attracted over 150 accredited investors and venture leaders, fostering a re-evaluation of early-stage capital and promoting pathways to higher-quality deal flow and liquidity.
- Rich Conference Content: The Atlanta event featured approximately 75 investors and over 20 presentations, showcasing 10 actively funding companies, highlighting the importance of education and networking for investors.
- Exit Strategy Optimization: The Philadelphia summit focused on accelerating exits, discussing how to extend traditional 5-7 year exit windows to 10-12 years, emphasizing the significance of disciplined portfolio strategies and capital structures.
- Future Outlook: Keiretsu Forum plans to continue its Investor Summit series in 2026, expecting to feature more local innovation-stage startups and further enhance the regional investment ecosystem.
MDB Capital Holdings to Hold Q3 2025 Update Conference Call on Thursday, November 20, 2025, at 4:30 PM ET
Webinar Announcement: MDB Capital Holdings, LLC will host a Zoom webinar on November 20, 2025, at 4:30 p.m. ET to provide a business update for Q3 2025, led by CEO Christopher Marlett.
Access Information: Investors can pre-register for the webinar and access it through MDB's investor relations website on the day of the event.
Company Overview: MDB Capital, founded in 1997, focuses on launching disruptive technology companies through public venture capital, emphasizing community-driven financings and early public offerings.
Forward-Looking Statements: The press release includes forward-looking statements that are subject to risks and uncertainties, and MDB does not intend to update these statements after the release date.
PatentVest Appoints Dr. Sarah Cork as Senior Patent Attorney, Enhancing Leadership in Life Sciences IP
Dr. Sarah Cork Joins PatentVest: Dr. Sarah Cork has been appointed as a Senior Patent Attorney at PatentVest, enhancing the firm's capabilities in the life sciences sector and intellectual property strategies.
Expertise and Leadership: With over a decade of experience in biotechnology and pharmaceuticals, Dr. Cork specializes in complex IP matters and is actively involved in the intellectual property community, serving in leadership roles and contributing to various organizations.
IPO Angels Teams Up with MDB Capital to Transform Early-Stage Investment Strategies
Launch of IPO Angels: IPO Angels, LLC has officially launched a new early-stage investing model in partnership with MDB Capital Holdings, connecting vetted companies with accredited investors and a successful IPO process.
Innovative Investment Approach: The platform combines the investor network of Keiretsu Forum's Mid-Atlantic, Southeast, and Texas regions with MDB Capital's expertise, offering a structured path for startups from Series A funding to IPO within 12 to 18 months.
Proven Track Record: Keiretsu Forum MST has facilitated over $39 million in investments and maintains a high conversion rate in angel investing, while MDB Capital boasts a 100% success rate in taking companies public.
Membership Benefits: Membership in IPO Angels is by invitation only for accredited investors, providing access to curated investment opportunities, educational resources, and structured rights that ensure liquidity within 90-180 days post-IPO.
MDB Capital Appoints New Board Member
- Board Changes: MDB Capital Holdings announced the appointment of Jeb Terry to its Board of Directors while expressing gratitude to Susanne Meline for her contributions, effective February 1, 2026, reflecting the company's ongoing commitment to leadership optimization.
- New Board Member Background: Jeb Terry brings over 20 years of investment experience in microcap medical and biotechnology sectors, having founded Aberdeen Investment Management with a focus on undervalued opportunities in life sciences, which is expected to provide MDB with valuable industry insights.
- Strategic Implications: The addition of the new board member is seen as a crucial step for MDB in expanding its founder and investor community, with CEO Christopher Marlett emphasizing that Terry's expertise will aid the company's further development in public venture capital.
- Future Outlook: MDB Capital remains committed to driving the growth of innovative companies through its unique public venture capital platform, focusing on early public offerings and follow-on financings to support promising enterprises.
Keiretsu Forum Hosts Successful Investor Conferences, Attracting Over 150 Investors
- Investor Gathering: The Southeast Investor Conference and Mid-Atlantic Investor Summit attracted over 150 accredited investors and family offices, fostering in-depth discussions on early-stage capital and developing pathways for higher-quality deal flow.
- Significant Outcomes: The Atlanta conference featured 75 investors and over 20 presentations, showcasing 10 actively funding companies, which significantly boosted investor confidence and engagement in the market.
- Exit Strategy Optimization: The Philadelphia summit emphasized disciplined portfolio strategies and time-to-exit, proposing structured financing and 'restart' strategies to shorten exit timelines, thereby enhancing investor return expectations.
- Future Outlook: Keiretsu Forum plans to continue its Investor Summit series in 2026, expecting to attract more local innovation-stage startups and further drive the development of the regional investment ecosystem.
Keiretsu Forum Hosts Successful Investor Conferences, Attracting Over 150 Investors
- Investor Gathering: The Southeast Investor Conference and Mid-Atlantic Investor Summit attracted over 150 accredited investors and venture leaders, fostering a re-evaluation of early-stage capital and promoting pathways to higher-quality deal flow and liquidity.
- Rich Conference Content: The Atlanta event featured approximately 75 investors and over 20 presentations, showcasing 10 actively funding companies, highlighting the importance of education and networking for investors.
- Exit Strategy Optimization: The Philadelphia summit focused on accelerating exits, discussing how to extend traditional 5-7 year exit windows to 10-12 years, emphasizing the significance of disciplined portfolio strategies and capital structures.
- Future Outlook: Keiretsu Forum plans to continue its Investor Summit series in 2026, expecting to feature more local innovation-stage startups and further enhance the regional investment ecosystem.
MDB Capital Holdings to Hold Q3 2025 Update Conference Call on Thursday, November 20, 2025, at 4:30 PM ET
Webinar Announcement: MDB Capital Holdings, LLC will host a Zoom webinar on November 20, 2025, at 4:30 p.m. ET to provide a business update for Q3 2025, led by CEO Christopher Marlett.
Access Information: Investors can pre-register for the webinar and access it through MDB's investor relations website on the day of the event.
Company Overview: MDB Capital, founded in 1997, focuses on launching disruptive technology companies through public venture capital, emphasizing community-driven financings and early public offerings.
Forward-Looking Statements: The press release includes forward-looking statements that are subject to risks and uncertainties, and MDB does not intend to update these statements after the release date.
PatentVest Appoints Dr. Sarah Cork as Senior Patent Attorney, Enhancing Leadership in Life Sciences IP
Dr. Sarah Cork Joins PatentVest: Dr. Sarah Cork has been appointed as a Senior Patent Attorney at PatentVest, enhancing the firm's capabilities in the life sciences sector and intellectual property strategies.
Expertise and Leadership: With over a decade of experience in biotechnology and pharmaceuticals, Dr. Cork specializes in complex IP matters and is actively involved in the intellectual property community, serving in leadership roles and contributing to various organizations.
IPO Angels Teams Up with MDB Capital to Transform Early-Stage Investment Strategies
Launch of IPO Angels: IPO Angels, LLC has officially launched a new early-stage investing model in partnership with MDB Capital Holdings, connecting vetted companies with accredited investors and a successful IPO process.
Innovative Investment Approach: The platform combines the investor network of Keiretsu Forum's Mid-Atlantic, Southeast, and Texas regions with MDB Capital's expertise, offering a structured path for startups from Series A funding to IPO within 12 to 18 months.
Proven Track Record: Keiretsu Forum MST has facilitated over $39 million in investments and maintains a high conversion rate in angel investing, while MDB Capital boasts a 100% success rate in taking companies public.
Membership Benefits: Membership in IPO Angels is by invitation only for accredited investors, providing access to curated investment opportunities, educational resources, and structured rights that ensure liquidity within 90-180 days post-IPO.
